Health News

Sensitivity to pain linked to differences in brain structure

Date: Jan-15-2014
Researchers in the US have discovered a new clue to why everybody feels pain differently - it could be because of individual differences in brain structure.Writing about their findings in a recent online issue of the journal Pain, scientists at Wake Forest Baptist Medical Center in Winston-Salem, NC, describe how they compared people's perceived pain intensity with differences in brain structure seen in MRI scans.

Cynapsus announces completion of human healthy volunteer crossover study results for APL-130277

Date: Jan-15-2014
Cynapsus Therapeutics Inc., a specialty pharmaceutical company, has announced positive top line data from its recently completed healthy volunteer pilot crossover trial comparing APL-130277, a sublingual thin film strip formulation of apomorphine, to a commercially available injectable formulation of apomorphine.

Anavex agreement with The Roskamp Institute to advance the clinical development of ANAVEX PLUS

Date: Jan-15-2014
Anavex Life Sciences Corp. has announced that they have established an agreement with The Roskamp Institute for the clinical development of ANAVEX PLUS, a new combination drug of ANAVEX 2-73 and donepezil (Aricept®) for the treatment of Alzheimer's disease. This study will evaluate the safety, tolerability, pharmacokinetics, and possible clinical benefits of ANAVEX PLUS in Alzheimer's disease patients and other diseases associated with dementia and cognitive impairment.

RCSI research breakthrough in understanding hereditary emphysema

Date: Jan-15-2014
Researchers from the Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital have made an important breakthrough in the understanding and treatment of hereditary emphysema. Their research findings were published in this month's edition of Science Translational Medicine, a prestigious journal that highlights medical advances resulting from scientific research, thus bridging the research-to-treatment gap. Their exciting findings show how the protein Alpha-1 Antitrypsin (AAT) plays an important role in controlling inflammation from white blood cells and its importance for good health.

Molecular nano-spies to make light work of disease detection

Date: Jan-15-2014
A world of cloak-and-dagger pharmaceuticals has come a step closer with the development of stealth compounds programmed to spring into action when they receive the signal.Researchers at the University of Nottingham's School of Pharmacy have designed and tested large molecular complexes that will reveal their true identity only when they've reached their intended target, like disguised saboteurs working deep behind enemy lines.

Freshwater turtles from wetlands can transmit Salmonella to humans

Date: Jan-15-2014
Professors from the University CEU Cardenal Herrera studied 200 specimens of freshwater turtles from eleven Valencian wetland areas, to determine the prevalence of Salmonella and Campylobacter in these animals, because of their potential risk of transmitting gastrointestinal diseases to humans, especially children. According to the results, published in the journal Plos One, 11% of the analysed specimens of freshwater turtles were found positive for Salmonella. However, Campylobacter was not detected in any of them.

New horizons in radiotherapy?

Date: Jan-15-2014
Targeted radiation therapy that is less harmful to healthy cells could see the light of day thanks to a team of French researchers from the Laboratoire de Chimie Physique - Matière et Rayonnement (CNRS/UPMC) working in collaboration with German and American scientists...

Test for early diagnosis of lung cancer subject of new Journal of Clinical Oncology paper

Date: Jan-15-2014
GENSIGNIA Ltd, a London-based privately held molecular diagnostics company with laboratory operations in San Diego, CA and Fondazione IRCCS, Istituto Nazionale dei Tumori (INT), Milan, a National Cancer Research Center in Italy, has announced that positive clinical validation results for the microRNA signature classifier (MSC) Lung Cancer assay were published in the Journal of Clinical Oncology (JCO).

A study analyses the health status of immigrant population in Raval neighbourhood in Barcelona

Date: Jan-15-2014
To know the incidence and risk factors for some diseases in Barcelona's immigrant population in Spain is the main objective of a study published in the Journal of Travel Medicine. The article is signed by experts Esther Esteban, from the Department of Animal Biology of the University of Barcelona, Olga Hladun and Albert Grau, doctors at the Catalan Institute of Health, and Josep M. Jansà, expert from the European Centre for Disease Prevention and Control (ECDC, Sweden).

ACell initiates post-market comparative study of Matristem® versus Dermagraft® in patients with diabetic foot ulcers

Date: Jan-15-2014
ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, has announced it has initiated, with multiple patients enrolled, a U.S. post-market clinical trial (NCT01858545) comparing the efficacy of MatriStem® to a leading cellular scaffold, Dermagraft®, for the treatment of patients with diabetic foot ulcers (DFUs) that failed to adequately heal following initial standard of care therapy.